Investment Banking
exclusively for the Healthcare
and Life Sciences Company Ecosystem Globally

A trusted partner leveraging decades of deep sector expertise and global reach to create value for Companies & Private Equity Funds from Growth Equity to 'Buy and Build' to Strategic Sale or Recapitalization

Commercialization & Healthcare Communications
Commercialization & Healthcare Communications
Commercialization & Healthcare Communications
Healthcare & Life Sciences IT
Healthcare & Life Sciences IT
Healthcare & Life Sciences IT
Healthcare & Life Sciences Consulting
Healthcare & Life Sciences Consulting
Healthcare & Life Sciences Consulting
Payer and Provider Services & Software
Payer and Provider Services & Software
Payer and Provider Services & Software
CROs & Regulatory affairs
CROs & Regulatory affairs
CROs & Regulatory affairs
Healthcare AI, Analytics & Insights
Healthcare AI, Analytics & Insights
Healthcare AI, Analytics & Insights
CDMOs & Laboratories
CDMOs & Laboratories
CDMOs & Laboratories
Biopharmaceuticals & Biotechnology
Biopharmaceuticals & Biotechnology
Biopharmaceuticals & Biotechnology
MedTech
MedTech
MedTech
Digital Health & HealthTech
Digital Health & HealthTech
Digital Health & HealthTech
Healthcare Providers
Healthcare Providers
Healthcare Providers
Healthcare BPO
Healthcare BPO
Healthcare BPO

Winner of the ‘Boutique Investment Banking Firm of the Year’ for the Third Year Running by The M&A Advisor

30

Countries we have
closed transactions in

14

Countries we have
offices in

110

Employees across the
Americas, Europe & APAC

25

Years we have
been operating

OUR TRACK RECORD

Laser Focus. Global Reach.

We strive to achieve premium valuations for sell side clients and help buyers scale globally by leveraging our deep healthcare and life sciences domain expertise, global reach and understanding of key valuation drivers

What our clients say about us

Trusted Advisor. Delivering Exceptional Outcomes

We are more than a healthcare and life sciences investment bank. We are your trusted advisors, focused on providing you with strategic M&A and private equity transaction advice and superior execution

We chose TH Global Capital Healthcare & Life Sciences Investment Banking because of their track record in healthcare and life sciences. They truly became an extension of our company and took the lead in all aspects of the transaction. Their deep understanding of the transaction process and guidance through all the stages was invaluable. We truly couldn’t have done it without the TH team. When we started, we had excellent TH advisors, now we have wonderful friends. John Strapp Co-Founder & Chairman, The Kinetix Group
TH’s impressive track record in the Life Sciences Consulting, Data Science and Digital Transformation spaces was evident through their extensive network of industry buyer and investor relationships and deep understanding of the landscape. Their hard work and commitment to success resulted in an outcome that exceeded our expectations both in terms of valuation and fit. TH Global Capital Healthcare & Life Sciences Investment Banking truly became an extension of the SUAZIO team, just as they promised! Christophe Van der Linden Founder & CEO, SUAZIO
TH Global Capital Healthcare & Life Sciences Investment Banking was our key partner, bringing expertise and strategic guidance throughout the transaction. The team worked incredibly hard and were always by our side throughout and effortlessly navigated through the transaction, providing us with sound advice and helping us find solutions to any unforeseen challenges. TH Global Capital's understanding of the Veeva ecosystem, and their global buyer and investor network helped us identify the right strategic partner. We are truly thankful for the TH team’s guidance and unwavering support throughout this process. Dionissis Nikolopoulos Founder & CEO, Aqurance
TH Global Capital Healthcare & Life Sciences Investment Banking ran a structured and highly professional sale process, securing a total of 12 offers from buyers globally, leveraging their extensive buyer relationships and deep expertise in the digital transformation and life sciences sectors. We would certainly recommend them to any company considering a sale - The level of advice provided from start to finish was of the highest calibre and was instrumental in ensuring that we found the ideal partner. Fonny Schenck Founder & CEO, Across Health
The TH Global Capital Healthcare & Life Sciences Investment Banking team was instrumental in helping us find a partner in Nemera that shares a common vision to provide exceptional capabilities to their clients, from innovation through industrialization. We appreciate TH Global Capital Healthcare & Life Sciences Investment Banking depth of experience in the healthcare sector and their understanding of our specialized design & development capabilities. Craig Scherer Co-Founder, Insight Product Development
From the get-go, TH Global Capital Healthcare & Life Sciences Investment Banking got to know our business as if it were their own. They made it their business to understand not just the numbers but the story behind them. They expertly developed and helped us shortlist a field of potential buyers and negotiated the best possible deal. In doing this they left no stone unturned and have helped secure an exciting future for the business. TH gave us the confidence to control the process and our own destiny. Bravo. Fred Bassett Chairman & Founder, Blue Latitude Health
TH Global Capital Healthcare & Life Sciences Investment Banking has been our trusted M&A adviser for many years, having worked closely with the SCIO Health Analytics team on a number of our acquisitions. Their deep understanding of the healthcare market, coupled with their global reach across the US and Europe, has added significant value in support of our strategic growth objectives. Siva Namasivayam CEO, SCIO Health Analytics
Technology Holdings is pleased to announce that it has acted as the exclusive financial advisor to SUAZIO, a leading data-driven Life Sciences and MedTech consultancy on its strategic sale to NAMSA, the world's leading MedTech CRO, an Archimed portfolio company headquartered in the United States.
Our Capabilities

Full Service Investment Banking

We provide a full suite of investment banking services, whether it's helping you realise the maximum value for your business, providing access to capital for growth or research, or providing a stellar return for your investors

Asset Management

With extensive asset management expertise, our team will optimize your portfolio, maximize returns, and mitigate risks. We’ll help you identify growth opportunities, enhancing performance, and create strategies for long term value.

IPO ADVISORY

We guide companies through every stage of going public,from IPO readiness and equity story development to regulatory navigation and execution, ensuring a successful market debut and lasting value creation.

WhatsApp LinkedIn